Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis

Keyphrases

• Experimental Autoimmune Encephalomyelitis 100%
• Glial Cell Activation 100%
• Multiple Sclerosis 66%
• Microglia 66%
• Astrocytes 66%
• Experimental Autoimmune Encephalomyelitis Mice 66%
• Central Nervous System 33%
• Multiple Sclerosis Treatment 33%
• Clinical Score 33%
• Spinal Cord 33%
• Chemokines 33%
• Activated Microglia 33%
• Microglial Activation 33%
• Oral Administration 33%
• Model Experimental 33%
• Disease Incidence 33%
• Pathological Examination 33%
• Astrocyte Activation 33%
• Glial Activation 33%
• Myelin Oligodendrocyte Glycoprotein 33%
• Activated Astrocytes 33%
• Animal Mortality 33%

Neuroscience

• Glial Cells 100%
• Cell Activation 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Microglia 80%
• Astrocyte 80%
• Multiple Sclerosis 40%
• Central Nervous System 20%
• Treatment of Multiple Sclerosis 20%
• Myelin Oligodendrocyte Glycoprotein 20%
• Chemokine 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Experimental Autoimmune Encephalomyelitis 100%
• Multiple Sclerosis 75%
• Chemokine 25%
• MOG-induced Experimental Autoimmune Encephalomyelitis 25%